325 related articles for article (PubMed ID: 29180403)
1. SUMOylation and ubiquitination reciprocally regulate α-synuclein degradation and pathological aggregation.
Rott R; Szargel R; Shani V; Hamza H; Savyon M; Abd Elghani F; Bandopadhyay R; Engelender S
Proc Natl Acad Sci U S A; 2017 Dec; 114(50):13176-13181. PubMed ID: 29180403
[TBL] [Abstract][Full Text] [Related]
2. Proteasome inhibition induces α-synuclein SUMOylation and aggregate formation.
Kim YM; Jang WH; Quezado MM; Oh Y; Chung KC; Junn E; Mouradian MM
J Neurol Sci; 2011 Aug; 307(1-2):157-61. PubMed ID: 21641618
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin ligase Nedd4 promotes alpha-synuclein degradation by the endosomal-lysosomal pathway.
Tofaris GK; Kim HT; Hourez R; Jung JW; Kim KP; Goldberg AL
Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17004-9. PubMed ID: 21953697
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination of alpha-synuclein by Siah-1 promotes alpha-synuclein aggregation and apoptotic cell death.
Lee JT; Wheeler TC; Li L; Chin LS
Hum Mol Genet; 2008 Mar; 17(6):906-17. PubMed ID: 18065497
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitination of alpha-synuclein and autophagy in Parkinson's disease.
Engelender S
Autophagy; 2008 Apr; 4(3):372-4. PubMed ID: 18216494
[TBL] [Abstract][Full Text] [Related]
6. Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.
Chu Y; Dodiya H; Aebischer P; Olanow CW; Kordower JH
Neurobiol Dis; 2009 Sep; 35(3):385-98. PubMed ID: 19505575
[TBL] [Abstract][Full Text] [Related]
7. Sumoylation inhibits alpha-synuclein aggregation and toxicity.
Krumova P; Meulmeester E; Garrido M; Tirard M; Hsiao HH; Bossis G; Urlaub H; Zweckstetter M; Kügler S; Melchior F; Bähr M; Weishaupt JH
J Cell Biol; 2011 Jul; 194(1):49-60. PubMed ID: 21746851
[TBL] [Abstract][Full Text] [Related]
8. Variable expression of mitochondrial complex IV in the course of nigral intracellular accumulation of α-synuclein.
Lang A; Dassler E; Milenkovic I; Lutz MI; Kovacs GG
Parkinsonism Relat Disord; 2021 Sep; 90():57-61. PubMed ID: 34385008
[TBL] [Abstract][Full Text] [Related]
9. SIAH proteins regulate the degradation and intra-mitochondrial aggregation of PINK1: Implications for mitochondrial pathology in Parkinson's disease.
Abd Elghani F; Safory H; Hamza H; Savyon M; Farhoud M; Toren-Hershoviz M; Vitic Z; Ebanks K; Shani V; Bisharat S; Shaulov L; Brodski C; Song Z; Bandopadhyay R; Engelender S
Aging Cell; 2022 Dec; 21(12):e13731. PubMed ID: 36307912
[TBL] [Abstract][Full Text] [Related]
10. p21-activated kinase 4 controls the aggregation of α-synuclein by reducing the monomeric and aggregated forms of α-synuclein: involvement of the E3 ubiquitin ligase NEDD4-1.
Won SY; Park JJ; You ST; Hyeun JA; Kim HK; Jin BK; McLean C; Shin EY; Kim EG
Cell Death Dis; 2022 Jun; 13(6):575. PubMed ID: 35773260
[TBL] [Abstract][Full Text] [Related]
11. Ginkgolic acid promotes autophagy-dependent clearance of intracellular alpha-synuclein aggregates.
Vijayakumaran S; Nakamura Y; Henley JM; Pountney DL
Mol Cell Neurosci; 2019 Dec; 101():103416. PubMed ID: 31654699
[TBL] [Abstract][Full Text] [Related]
12. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
[TBL] [Abstract][Full Text] [Related]
13. The SUMO Conjugase Ubc9 Protects Dopaminergic Cells from Cytotoxicity and Enhances the Stability of α-Synuclein in Parkinson's Disease Models.
Verma DK; Ghosh A; Ruggiero L; Cartier E; Janezic E; Williams D; Jung EG; Moore M; Seo JB; Kim YH
eNeuro; 2020; 7(5):. PubMed ID: 32887693
[TBL] [Abstract][Full Text] [Related]
14. Interplay between sumoylation and phosphorylation for protection against α-synuclein inclusions.
Shahpasandzadeh H; Popova B; Kleinknecht A; Fraser PE; Outeiro TF; Braus GH
J Biol Chem; 2014 Nov; 289(45):31224-40. PubMed ID: 25231978
[TBL] [Abstract][Full Text] [Related]
15. Enhanced ubiquitin-dependent degradation by Nedd4 protects against α-synuclein accumulation and toxicity in animal models of Parkinson's disease.
Davies SE; Hallett PJ; Moens T; Smith G; Mangano E; Kim HT; Goldberg AL; Liu JL; Isacson O; Tofaris GK
Neurobiol Dis; 2014 Apr; 64(100):79-87. PubMed ID: 24388974
[TBL] [Abstract][Full Text] [Related]
16. α-synuclein aggregation reduces nigral myocyte enhancer factor-2D in idiopathic and experimental Parkinson's disease.
Chu Y; Mickiewicz AL; Kordower JH
Neurobiol Dis; 2011 Jan; 41(1):71-82. PubMed ID: 20816781
[TBL] [Abstract][Full Text] [Related]
17. SUMOylation of the transcription factor ZFHX3 at Lys-2806 requires SAE1, UBC9, and PIAS2 and enhances its stability and function in cell proliferation.
Wu R; Fang J; Liu M; A J; Liu J; Chen W; Li J; Ma G; Zhang Z; Zhang B; Fu L; Dong JT
J Biol Chem; 2020 May; 295(19):6741-6753. PubMed ID: 32249212
[TBL] [Abstract][Full Text] [Related]
18. Human Polycomb protein 2 promotes α-synuclein aggregate formation through covalent SUMOylation.
Oh Y; Kim YM; Mouradian MM; Chung KC
Brain Res; 2011 Mar; 1381():78-89. PubMed ID: 21256122
[TBL] [Abstract][Full Text] [Related]
19. SUMOylation at K340 inhibits tau degradation through deregulating its phosphorylation and ubiquitination.
Luo HB; Xia YY; Shu XJ; Liu ZC; Feng Y; Liu XH; Yu G; Yin G; Xiong YS; Zeng K; Jiang J; Ye K; Wang XC; Wang JZ
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16586-91. PubMed ID: 25378699
[TBL] [Abstract][Full Text] [Related]
20. Ubiquitination increases parkin activity to promote autophagic α-synuclein clearance.
Lonskaya I; Desforges NM; Hebron ML; Moussa CE
PLoS One; 2013; 8(12):e83914. PubMed ID: 24386307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
